Skip to main content

05-12-2014 | Hematologic cancers | Book chapter | Article

7. Functional Imaging in Hodgkin Lymphoma

Authors: Andrea Gallamini, Martin Hutchings, Anna Borra

Publisher: Springer International Publishing


Hodgkin lymphoma (HL) has become a curable malignancy with more than 90 % of patients alive and 80 % considered cured after a minimum follow-up of 6 years. These results have been obtained by a combination of factors influencing treatment outcome in different ways. These can be briefly summarised: (a) a high chemo- and radiosensitivity of the tumour, (b) an increasing accuracy of staging procedures, and (c) different treatment strategies tailored to well-defined categories of patients with a different risk of treatment failure.

Please log in to get access to this content

Related topics